这是一篇来自已证抗体库的有关人类 CD80的综述,是根据116篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD80 抗体。
CD80 同义词: B7; B7-1; B7.1; BB1; CD28LG; CD28LG1; LAB7

BioLegend
小鼠 单克隆(2D10)
  • 流式细胞仪; 小鼠; 1:100; 图 1k
BioLegend CD80抗体(Biolegend, 305221)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 1k). Nat Commun (2021) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 3s2b
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 3s2b). elife (2020) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 s1c
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 s1c). BMC Cancer (2020) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 4s2a
BioLegend CD80抗体(Biolegend, 305225)被用于被用于流式细胞仪在人类样本上 (图 4s2a). elife (2020) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 1:100; 图 s20c
BioLegend CD80抗体(Biolegend, 305222)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s20c). Nat Commun (2020) ncbi
小鼠 单克隆(2D10)
  • mass cytometry; 人类; 0.5 mg/ml; 图 s11a
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于mass cytometry在人类样本上浓度为0.5 mg/ml (图 s11a). Nature (2020) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 1 ug/ml; 图 s3a
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上浓度为1 ug/ml (图 s3a). Science (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 6b
BioLegend CD80抗体(Biolegend, 305222)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Rep (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 5b
BioLegend CD80抗体(Biolegend, 305220)被用于被用于流式细胞仪在人类样本上 (图 5b). elife (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 3c
BioLegend CD80抗体(Biolegend, 305221)被用于被用于流式细胞仪在人类样本上 (图 3c). Cell Rep (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 3b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 3b). Sci Rep (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 4e
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 4e). Nat Med (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 1:50; 图 s6a
BioLegend CD80抗体(BioLegend, 305220)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s6a). Nat Commun (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1b). BMC Immunol (2019) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1b). Front Immunol (2018) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 6f
BioLegend CD80抗体(Biolegend, 305218)被用于被用于流式细胞仪在人类样本上 (图 6f). Ann Rheum Dis (2018) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 s1b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 s1b). Mol Biol Cell (2018) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 2b
BioLegend CD80抗体(Biolegend, 305218)被用于被用于流式细胞仪在人类样本上 (图 2b). Cell Death Dis (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2017) ncbi
小鼠 单克隆(2D10)
  • mass cytometry; 人类; 图 2a
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 5b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 5b). Science (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 s6a
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 s6a). MBio (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 1:50; 图 s1d
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s1d). Nat Commun (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD80抗体(BioLegend, 305207)被用于被用于流式细胞仪在人类样本上 (图 4a). Oncoimmunology (2016) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 表 3
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD80抗体(Biolegend, 305221)被用于被用于流式细胞仪在人类样本上 (图 1b). Front Immunol (2016) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 2b
BioLegend CD80抗体(BioLegend, 305206)被用于被用于流式细胞仪在人类样本上 (图 2b). Oncogene (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1a). Sci Rep (2016) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 表 1
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 s6b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 s6b). Oncotarget (2016) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol Methods (2016) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol Res (2015) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 3
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 3). J Exp Med (2015) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类
BioLegend CD80抗体(Biolegend, 305217)被用于被用于流式细胞仪在人类样本上. Tissue Eng Part A (2015) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 4
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 4). Toxicol Sci (2015) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类
BioLegend CD80抗体(Biolegend, 2D10)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 小鼠
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 4b
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 4b). Exp Gerontol (2014) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD80抗体(BioLegend, 2D10)被用于被用于流式细胞仪在人类样本上 (图 2a). J Leukoc Biol (2014) ncbi
赛默飞世尔
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD80抗体(Invitrogen, MA1-10288)被用于被用于流式细胞仪在人类样本上 (图 1a). Rev Soc Bras Med Trop (2016) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD80抗体(Invitrogen, MHCD8001- FITC)被用于被用于流式细胞仪在人类样本上 (表 1). J Steroid Biochem Mol Biol (2017) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(生活技术, MEM-233)被用于被用于流式细胞仪在人类样本上. Sci Rep (2015) ncbi
小鼠 单克隆(2D10.4)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(eBioscience, 2D10.4)被用于被用于流式细胞仪在人类样本上. PLoS Negl Trop Dis (2014) ncbi
小鼠 单克隆(2D10.4)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(eBioscience, 2D10.4)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(2D10.4)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(eBioscence, 2D10.4)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(2D10.4)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(eBioscience, 2D10.4)被用于被用于流式细胞仪在人类样本上. Immunology (2015) ncbi
小鼠 单克隆(2D10.4)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(eBioscience, 2D10.4)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (2014) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag Laboratories, clone EM-233)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(2D10.4)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Biosource, 2D10)被用于被用于流式细胞仪在人类样本上. J Immunol (2011) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2009) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD80抗体(Caltag, MEM233)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2008) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2007) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; African green monkey
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在African green monkey样本上. Vet Immunol Immunopathol (2007) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上. Immunology (2007) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上 (表 1). Blood (2007) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 表 2
  • 免疫细胞化学; 人类; 图 2d
赛默飞世尔 CD80抗体(Caltag, MEM233)被用于被用于流式细胞仪在人类样本上 (表 2) 和 被用于免疫细胞化学在人类样本上 (图 2d). Immunology (2006) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag, MEM233)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2006) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上. Haematologica (2006) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD80抗体(Caltag, MHCD8001)被用于被用于流式细胞仪在人类样本上 (表 1). Stem Cells (2006) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag, MEM233)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2005) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag, MHCD8001)被用于被用于流式细胞仪在人类样本上. Mol Immunol (2005) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔 CD80抗体(Caltag, MEM 233)被用于被用于流式细胞仪在人类样本上 (图 6). Immunology (2005) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上. J Immunol (2004) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD80抗体(Caltag, MEM-233)被用于被用于流式细胞仪在人类样本上 (图 1). Int Immunol (2003) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR1157(2))
  • 免疫组化-石蜡切片; 人类; 图 6d
艾博抗(上海)贸易有限公司 CD80抗体(Abcam, ab134120)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6d). Mol Cancer (2021) ncbi
domestic rabbit 单克隆(EPR1157(2))
  • 免疫组化-石蜡切片; 人类; 图 s7d
艾博抗(上海)贸易有限公司 CD80抗体(Abcam, ab134120)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s7d). Cell (2019) ncbi
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
艾博抗(上海)贸易有限公司 CD80抗体(Abcam, ab8239)被用于被用于流式细胞仪在人类样本上. Int J Mol Sci (2014) ncbi
domestic rabbit 单克隆(EPR1157(2))
  • 免疫组化-石蜡切片; 人类; 1:100
艾博抗(上海)贸易有限公司 CD80抗体(Abcam, ab134120)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Int J Cardiol (2014) ncbi
美天旎
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1a
美天旎 CD80抗体(Miltenyi Biotec, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1a). Eur J Pharm Biopharm (2017) ncbi
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 图 1
美天旎 CD80抗体(Miltenyi Biotec, 2D10)被用于被用于流式细胞仪在人类样本上 (图 1). Inflammation (2016) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(MEM-233)
  • 流式细胞仪; 人类
伯乐(Bio-Rad)公司 CD80抗体(AbD Serotec, MEM-233)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(2D10)
  • 流式细胞仪; 人类; 1:10; 图 3
圣克鲁斯生物技术 CD80抗体(Santa Cruz, sc-73382)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 3). Mol Med Rep (2016) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(MAB104)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD80抗体(Beckman Coulter, MAB104)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2014) ncbi
碧迪BD
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 2c, 4b
碧迪BD CD80抗体(BD, L307.4)被用于被用于流式细胞仪在人类样本上 (图 2c, 4b). Rheumatology (Oxford) (2020) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD80抗体(BD, L307.4)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 3e
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 3e). Proc Natl Acad Sci U S A (2019) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 s4a
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 s4a). Cancer (2019) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 3f
碧迪BD CD80抗体(BD, 563084)被用于被用于流式细胞仪在人类样本上 (图 3f). J Clin Invest (2018) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 4a). Front Immunol (2017) ncbi
小鼠 单克隆(L307.4)
  • mass cytometry; 人类; 图 s3a
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于mass cytometry在人类样本上 (图 s3a). Science (2017) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD80抗体(Becton Dickinson, L307.4)被用于被用于流式细胞仪在人类样本上 (图 5a). J Leukoc Biol (2017) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 s9a
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 s9a). PLoS Pathog (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD80抗体(BD Bioscience, L307.4)被用于被用于流式细胞仪在人类样本上 (图 2b). Immunol Cell Biol (2017) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 7a
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 7a). PLoS ONE (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 s4j
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 s4j). J Immunol (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD80抗体(BD Pharmingen, L307.4)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD80抗体(BD PharMingen, 561135)被用于被用于流式细胞仪在人类样本上 (图 5). Oncoimmunology (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD, L307.4)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 2B
碧迪BD CD80抗体(BD, 560442)被用于被用于流式细胞仪在人类样本上 (图 2B). Reproduction (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; African green monkey; 图 2b
碧迪BD CD80抗体(BD, L307.4)被用于被用于流式细胞仪在African green monkey样本上 (图 2b). J Med Primatol (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 1:200; 图 7g
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7g). Nat Commun (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 1:20; 表 2
碧迪BD CD80抗体(BD PharMingen, 560442)被用于被用于流式细胞仪在人类样本上浓度为1:20 (表 2). Oncoimmunology (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD80抗体(BD, 557227)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上 (图 st1). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 7c
碧迪BD CD80抗体(BD Bioscience, L307.4)被用于被用于流式细胞仪在人类样本上 (图 7c). PLoS ONE (2016) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD80抗体(BD Pharmingen, 560926)被用于被用于流式细胞仪在人类样本上 (图 2a). Mol Med Rep (2016) ncbi
小鼠 单克隆(BB1)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD80抗体(BD Biosciences, BB1)被用于被用于流式细胞仪在人类样本上 (图 s2). Sci Transl Med (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD80抗体(BD Biosciences, 557226)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD80抗体(BD Biosciences, 560925)被用于被用于流式细胞仪在人类样本上 (图 1). Mol Med Rep (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(Pharmingen, 557227)被用于被用于流式细胞仪在人类样本上. Springerplus (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD80抗体(BD Biosciences, 557227)被用于被用于流式细胞仪在人类样本上 (表 1). Exp Ther Med (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD Pharmingen, clone L307.4)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 猕猴
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在猕猴样本上. J Leukoc Biol (2015) ncbi
小鼠 单克隆(BB1)
  • 免疫组化-石蜡切片; 人类; 1:100
碧迪BD CD80抗体(BD Biosciences, 555683)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Mol Med Rep (2015) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类; 图 5
碧迪BD CD80抗体(BD, L307.4)被用于被用于流式细胞仪在人类样本上 (图 5). Clin Cancer Res (2015) ncbi
小鼠 单克隆(L307.4)
  • 免疫细胞化学; 人类
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; African green monkey; 图 2
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在African green monkey样本上 (图 2). PLoS Pathog (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD Biosciences, L307.4)被用于被用于流式细胞仪在人类样本上. Mol Immunol (2014) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; 人类
碧迪BD CD80抗体(BD, 560925)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(L307.4)
  • 流式细胞仪; South American squirrel monkey
碧迪BD CD80抗体(BDIS, L307.4)被用于被用于流式细胞仪在South American squirrel monkey样本上. J Immunol Methods (2005) ncbi
文章列表
  1. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed 出版商
  2. Arenas E, Martínez Sabadell A, Rius Ruiz I, Román Alonso M, Escorihuela M, Luque A, et al. Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation. Nat Commun. 2021;12:1237 pubmed 出版商
  3. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed 出版商
  4. Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed 出版商
  5. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed 出版商
  6. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed 出版商
  7. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed 出版商
  8. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed 出版商
  9. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed 出版商
  10. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed 出版商
  11. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed 出版商
  12. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed 出版商
  13. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed 出版商
  14. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed 出版商
  15. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed 出版商
  16. Frank A, Ebersberger S, Fink A, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135 pubmed 出版商
  17. Tremblay McLean A, Coenraads S, Kiani Z, Dupuy F, Bernard N. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. BMC Immunol. 2019;20:8 pubmed 出版商
  18. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed 出版商
  19. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed 出版商
  20. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed 出版商
  21. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed 出版商
  22. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  23. Sarkar M, Hile G, Tsoi L, Xing X, Liu J, Liang Y, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018;77:1653-1664 pubmed 出版商
  24. Redka D, Gutschow M, Grinstein S, Canton J. Differential ability of proinflammatory and anti-inflammatory macrophages to perform macropinocytosis. Mol Biol Cell. 2018;29:53-65 pubmed 出版商
  25. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed 出版商
  26. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed 出版商
  27. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed 出版商
  28. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  29. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  30. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed 出版商
  31. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed 出版商
  32. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed 出版商
  33. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed 出版商
  34. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed 出版商
  35. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  36. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  37. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed 出版商
  38. Bull C, Collado Camps E, Kers Rebel E, Heise T, Søndergaard J, den Brok M, et al. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol. 2017;95:408-415 pubmed 出版商
  39. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed 出版商
  40. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed 出版商
  41. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  42. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  43. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed 出版商
  44. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed 出版商
  45. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed 出版商
  46. Rosskopf S, Jutz S, Neunkirchner A, Candia M, Jahn Schmid B, Bohle B, et al. Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens. Sci Rep. 2016;6:31580 pubmed 出版商
  47. Loegl J, Hiden U, Nussbaumer E, Schliefsteiner C, Cvitic S, Lang I, et al. Hofbauer cells of M2a, M2b and M2c polarization may regulate feto-placental angiogenesis. Reproduction. 2016;152:447-55 pubmed 出版商
  48. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed 出版商
  49. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  50. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  51. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed 出版商
  52. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  53. Silva S, Levy D, Ruiz J, de Melo T, Isaac C, Fidelis M, et al. Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death. J Steroid Biochem Mol Biol. 2017;169:164-175 pubmed 出版商
  54. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  55. Lin R, Zhang J, Zhou L, Wang B. Altered function of monocytes/macrophages in patients with autoimmune hepatitis. Mol Med Rep. 2016;13:3874-80 pubmed 出版商
  56. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  57. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed 出版商
  58. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed 出版商
  59. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed 出版商
  60. Jutz S, Leitner J, Schmetterer K, Doel Perez I, Majdic O, Grabmeier Pfistershammer K, et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1. J Immunol Methods. 2016;430:10-20 pubmed 出版商
  61. Wang H, Feng F, Wang X, Wang R, Wu Y, Zhu M, et al. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Mol Med Rep. 2016;13:1077-82 pubmed 出版商
  62. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  63. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  64. Fricke F, Beaudouin J, Eils R, Heilemann M. One, two or three? Probing the stoichiometry of membrane proteins by single-molecule localization microscopy. Sci Rep. 2015;5:14072 pubmed 出版商
  65. Iwabuchi M, Narita M, Uchiyama T, Iwaya S, Oiwa E, Nishizawa Y, et al. Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene. Mol Med Rep. 2015;12:2443-50 pubmed 出版商
  66. Donis Maturano L, Sánchez Torres L, Cerbulo Vázquez A, Chacón Salinas R, García Romo G, Orozco Uribe M, et al. Prolonged exposure to neutrophil extracellular traps can induce mitochondrial damage in macrophages and dendritic cells. Springerplus. 2015;4:161 pubmed 出版商
  67. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed 出版商
  68. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed 出版商
  69. Musson D, Naot D, Chhana A, Matthews B, McIntosh J, Lin S, et al. In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regeneration. Tissue Eng Part A. 2015;21:1539-51 pubmed 出版商
  70. Reiner A, Heldt S, Presley C, Guley N, Elberger A, Deng Y, et al. Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189. Int J Mol Sci. 2014;16:758-87 pubmed 出版商
  71. Phadnis Moghe A, Crawford R, Kaminski N. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicol Sci. 2015;144:39-50 pubmed 出版商
  72. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed 出版商
  73. Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
  74. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  75. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  76. Neumann B, Klippert A, Raue K, Sopper S, Stahl Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol. 2015;97:19-30 pubmed 出版商
  77. Liao S, Ding T, Rao X, Sun D, Sun P, Wang Y, et al. Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease. Mol Med Rep. 2015;11:219-25 pubmed 出版商
  78. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed 出版商
  79. Å krnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed 出版商
  80. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed 出版商
  81. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  82. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  83. Royle C, Graham D, Sharma S, Fuchs D, Boasso A. HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs. J Immunol. 2014;193:3538-48 pubmed 出版商
  84. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed 出版商
  85. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed 出版商
  86. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  87. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed 出版商
  88. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed 出版商
  89. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  90. Moreno Fernandez M, Joedicke J, Chougnet C. Regulatory T Cells Diminish HIV Infection in Dendritic Cells - Conventional CD4(+) T Cell Clusters. Front Immunol. 2014;5:199 pubmed 出版商
  91. Müller A, Mu L, Meletta R, Beck K, Rancic Z, Drandarov K, et al. Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules. Int J Cardiol. 2014;174:503-15 pubmed 出版商
  92. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed 出版商
  93. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed 出版商
  94. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed 出版商
  95. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed 出版商
  96. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed 出版商
  97. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed 出版商
  98. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed 出版商
  99. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed 出版商
  100. Kim J, Park C, Park C, Jeoung D, Kim Y, Choe J. Beraprost enhances the APC function of B cells by upregulating CD86 expression levels. J Immunol. 2011;186:3866-73 pubmed 出版商
  101. Tanaka M, Krutzik S, Sieling P, Lee D, Rea T, Modlin R. Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses. J Immunol. 2009;183:2349-55 pubmed 出版商
  102. Stephens T, Nikoopour E, Rider B, Leon Ponte M, Chau T, Mikolajczak S, et al. Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E. J Immunol. 2008;181:6859-71 pubmed
  103. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  104. Daubenberger C, Spirig R, Patarroyo M, Pluschke G. Flow cytometric analysis on cross-reactivity of human-specific CD monoclonal antibodies with splenocytes of Aotus nancymaae, a non-human primate model for biomedical research. Vet Immunol Immunopathol. 2007;119:14-20 pubmed
  105. Gigli G, Caielli S, Cutuli D, Falcone M. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. Immunology. 2007;122:409-17 pubmed
  106. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  107. Sandilands G, McCrae J, Hill K, Perry M, Baxter D. Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils. Immunology. 2006;119:562-71 pubmed
  108. Summers K, Marleau A, Mahon J, McManus R, Hramiak I, Singh B. Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol. 2006;121:81-9 pubmed
  109. Campioni D, Moretti S, Ferrari L, Punturieri M, Castoldi G, Lanza F. Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematologic disorders: correlation with bone marrow microenvironment. Haematologica. 2006;91:364-8 pubmed
  110. McIntosh K, Zvonic S, Garrett S, Mitchell J, Floyd Z, Hammill L, et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells. 2006;24:1246-53 pubmed
  111. Game D, Rogers N, Lechler R. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am J Transplant. 2005;5:1614-25 pubmed
  112. Kokkinopoulos I, Jordan W, Ritter M. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol Immunol. 2005;42:957-68 pubmed
  113. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  114. Sandilands G, Ahmed Z, Perry N, Davison M, Lupton A, Young B. Cross-linking of neutrophil CD11b results in rapid cell surface expression of molecules required for antigen presentation and T-cell activation. Immunology. 2005;114:354-68 pubmed
  115. Zingoni A, Sornasse T, Cocks B, Tanaka Y, Santoni A, Lanier L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol. 2004;173:3716-24 pubmed
  116. Vasu C, Wang A, Gorla S, Kaithamana S, Prabhakar B, Holterman M. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties. Int Immunol. 2003;15:167-75 pubmed